Nu-Med Plus (NUMD) Return on Capital Employed Growth (1y) (2014 - 2025)
Nu-Med Plus (NUMD) Return on Capital Employed Growth (1y) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.94 Bn | 176.64 Bn | 6.27 Bn | -81.00 |
| 2 | Stryker | 128.78 Bn | 125.90 Bn | 3.81 Bn | -1,390.00 |
| 3 | Medtronic | 109.01 Bn | 99.79 Bn | 6.41 Bn | 39.00 |
| 4 | Boston Scientific | 68.59 Bn | 67.13 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 47.66 Bn | 43.99 Bn | 1.29 Bn | -110.00 |
| 6 | GE HealthCare Technologies | 28.36 Bn | 26.07 Bn | 1.98 Bn | -3,185.00 |
| 7 | Dexcom | 28.30 Bn | 27.18 Bn | 750.30 Mn | 658.00 |
| 8 | Smith & Nephew | 26.93 Bn | 26.36 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.33 Bn | 2.07 Bn | 125.00 |
| 10 | Nu-Med Plus | 1.67 Mn | 1.67 Mn | - | -1,132.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1,132.00 |
| Sep 30, 2025 | -3,517.00 |
| Jun 30, 2025 | -3,482.00 |
| Mar 31, 2025 | -4,223.00 |
| Dec 31, 2024 | -5,294.00 |
| Sep 30, 2024 | -535.00 |
| Jun 30, 2024 | -5,247.00 |
| Mar 31, 2024 | -11,596.00 |
| Dec 31, 2023 | -9,777.00 |
| Sep 30, 2023 | -4,833.00 |
| Jun 30, 2023 | -3,109.00 |
| Mar 31, 2023 | -11,360.00 |
| Dec 31, 2022 | -53,249.00 |
| Sep 30, 2022 | -230,581.00 |
| Jun 30, 2022 | 176,510.00 |
| Mar 31, 2022 | 95,704.00 |
| Dec 31, 2021 | 109,715.00 |
| Sep 30, 2021 | 293,418.00 |
| Jun 30, 2021 | 610,587.00 |
| Mar 31, 2021 | -86,711.00 |